IP Library › Granted Patent US 12,532,886
Granted Patent B2
US 12,532,886 · App. 17/345,277 · Granted Jan 27, 2026

Method of killing microbes using C3-C5 n-alkyl-gamma-butyrolactams and antimicrobial compositions containing same

Inventor: Faraz A. Alderson (Oakville, CA)
Assignee: VIROX TECHNOLOGIES INC.
A01N43/36A01N25/02A01N25/30A01N37/02A01N37/06A01N37/10A01N37/36A01N37/40A01N43/08A61K8/4913A61Q17/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,532,886
App. No.
17/345,277
Granted
Jan 27, 2026
Kind
B2
Abstract

Method of reducing the microbial load on a surface contaminated with microbes, the method comprising (a) identifying a surface in need of microbial reduction; and (b) applying an effective amount of an antimicrobial composition to the surface for a contact time and at a temperature sufficient to reduce the microbial load by at least 50%, wherein the antimicrobial composition comprises: (i) an effective amount of an antimicrobial agent consisting of at least one compound according to Formula 1: wherein R1 is a branched or unbranched, saturated or unsaturated, unsubstituted C3 to C5 alkyl chain or a C3 alkyl chain substituted with a methoxy group; and (ii) a diluent, q.s. to 100; and wherein the antimicrobial composition is substantially free of peroxygen compounds, antibiotics, and chloroacetamide.

Claims (18)

1 . A method of reducing a load of mycobacteria on a surface contaminated therewith, the method comprising applying an effective amount of an antimicrobial composition comprising a first antimicrobial agent to the surface, wherein the first antimicrobial agent consists of at least one compound according to Formula 1:

wherein R1 is a branched or unbranched, saturated or unsaturated, unsubstituted C3 to C5 alkyl chain or a C3 alkyl chain substituted with a methoxy group, and wherein at a contact time of 10 minutes, the first antimicrobial agent is effective to reduce the microbial load by at least 50%.

2 . The method of claim 1 , wherein the first antimicrobial agent is a C4 N-alkyl-gamma-butyrolactam.

3 . The method of claim 2 , wherein the first antimicrobial agent is selected from the group consisting of N-butyl-gamma-butyrolactam, N-isobutyl-gamma-butyrolactam, and N-methoxypropyl-gamma-butyrolactam.

4 . The method of claim 1 , wherein the antimicrobial composition further comprises an effective amount of at least one second antimicrobial agent selected from the group consisting of inorganic or organic acids and salts thereof, solvents, anionic surfactants, amphoteric surfactants, quaternary ammonium compounds, phenols, aldehydes, biguanides, terpenes, essential oils, mineral acids, halogen compounds, and antimicrobial metals, and wherein the antimicrobial composition is substantially free of peroxygen compounds, antibiotics, and chloroacetamide.

5 . The method of claim 4 , wherein at least one antimicrobial metal is present in the antimicrobial composition.

6 . The method of claim 5 , wherein at least one of formic acid, benzoic acid, salicylic acid, 2-furoic acid, mandelic acid, acetic acid, dimethylol propionic acid, gallic acid, malic acid, lactic acid, citric acid, sulfosalicylic acid, sulfosuccinic acid, glycolic acid, oxalic acid, propionic acid, maleic acid, ascorbic acid, neopentanoic acid, malonic acid, succinic acid, glutaric acid, and salts thereof is present in the antimicrobial composition.

7 . The method of claim 6 , wherein at least one of formic acid, salicylic acid, 2-furoic acid, mandelic acid, acetic acid, dimethylol propionic acid, gallic acid, malic acid, lactic acid, citric acid, and salts thereof is present in the antimicrobial composition.

8 . The method of claim 6 , wherein at least one of formic acid, salicylic acid, 2-furoic acid, benzoic acid, mandelic acid, acetic acid, dimethylol propionic acid, gallic acid, malic acid, lactic acid and salts thereof is present; and wherein at least one of citric acid and salts thereof is also present.

9 . The method of claim 5 , wherein the antimicrobial composition further comprises at least one antimicrobial solvent selected from the group consisting of C1-C8 alcohols, cyclic alcohols, dibasic esters, ethylhexylglycerin, butyl-3-hydroxybutyrate and glycol ethers.

10 . The method of claim 9 , wherein the at least one antimicrobial solvent is selected from the group consisting of ethanol, propanol, n-butanol, tert-butanol, phenethyl alcohol, isopropanol, benzyl alcohol, phenoxyethanol, furfuryl alcohol, dimethyl adipate, dimethyl succinate, dimethyl glutarate, butyl-3-hydroxybutyrate, and ethylhexylglycerin.

11 . The method of claim 5 , wherein the antimicrobial composition further comprises at least one anionic surfactant.

12 . The method of claim 11 , wherein the at least one anionic surfactant is selected from the group consisting of alkyl sulfuric acids, alkyl ether sulfuric acids, alkyl sulfonic acids, alkyl aryl sulfonic acids, alkyl phosphoric acid esters, alkyl carboxylic acids, alkyl ether carboxylic acids, acylamino acids, and salts thereof.

13 . The method of claim 4 , wherein the antimicrobial composition further comprises water as a diluent.

14 . The method of claim 13 , wherein the antimicrobial composition further comprises an effective amount of a pH adjusting agent.

15 . The method of claim 4 , wherein the antimicrobial composition further comprises an effective amount of at least one ingredient selected from the group consisting of chelating agents, stabilizing agents, buffering agents, nonionic surfactants, cationic surfactants, amphoteric surfactants, hydrotropes, skin conditioning agents, anti-foaming agents, builders, soil suspenders, anti-redeposition agents, brightening agents, radical scavengers, dyes, fragrances, rheology modifiers, emulsifiers, corrosion inhibitors, softening agents, anti-static agents, anti-wrinkling agents, dye transfer inhibition agents, color protection agents, odor removal agents, odor capturing agents, soil shielding agents, soil releasing agents, ultraviolet light protection agents, water repellency agents, insect repellency agents, anti-pilling agents, souring agents, mildew removing agents, film-forming agents, plasticizers, and allergicides.

16 . The method of claim 4 , wherein the contact time is from about 10 seconds to about 10 minutes.

17 . The method of claim 1 , wherein the temperature is from about −10° C. to about 60° C.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2024
From: ALDERSON, FARAZ A.
To: VIROX TECHNOLOGIES INC.
Reel/Frame 068524/0167 →
Continuity (4)
Continuation In Part 16830539 · Mar 26, 2020
Continuation PCTCA2019051740 · Dec 4, 2019
Provisional Application 62774964 · Dec 4, 2018
Related Publication 20210307327A1 · Oct 7, 2021
References Cited (53)
US 4132781A · Stoughton · 1979 [cited by applicant]
US 4305749A · Mildenberger et al. · 1981 [cited by applicant]
US 4782078A · Crawford et al. · 1988 [cited by applicant]
US 4885371A · Tracy et al. · 1989 [cited by applicant]
US 5035859A · Gu et al. · 1991 [cited by applicant]
US 5130124A · Merianos et al. · 1992 [cited by applicant]
US 5422073A · Mowrey-McKee et al. · 1995 [cited by applicant]
US 5762719A · D'Muhala et al. · 1998 [cited by applicant]
US 5972237A · Muller et al. · 1999 [cited by applicant]
US 6017863A · Cala et al. · 2000 [cited by applicant]
US 6100227A · Burlew · 2000 [cited by applicant]
US 6828277B2 · Manzer · 2004 [cited by applicant]
US 7419944B2 · Mowrey-McKee et al. · 2008 [cited by applicant]
US 7485619B2 · Kim et al. · 2009 [cited by applicant]
US 7666823B2 · Minick · 2010 [cited by applicant]
US 8268763B2 · Lane et al. · 2012 [cited by applicant]
US 9167812B2 · Bigorra Llosas · 2015 [cited by applicant]
US 20040192933A1 · Manzer et al. · 2004 [cited by applicant]
US 20070270612A1 · Pompeo et al. · 2007 [cited by applicant]
US 20080095863A1 · Kabra · 2008 [cited by applicant]
US 20180002645A1 · Bartley et al. · 2018 [cited by applicant]
US 20180055048A1 · Premachandran · 2018 [cited by applicant]
US 20190330489A1 · Dukhopelnikov · 2019 [cited by applicant]
CA 2007239 · 1990 [cited by applicant]
CN 103191050 · 2013 [cited by applicant]
CN 103191050A · 2013 [cited by applicant]
GB 1169113 · 1969 [cited by applicant]
GB 1525120 · 1978 [cited by applicant]
JP 73003394 · 1973 [cited by applicant]
JP 2007031299 · 2007 [cited by applicant]
WO 9521238 · 1995 [cited by applicant]
WO 199602624 · 1996 [cited by applicant]
WO 200250225 · 2002 [cited by applicant]
WO 200250241 · 2002 [cited by applicant]
WO 2003006046 · 2003 [cited by applicant]
WO 2003094920 · 2003 [cited by applicant]
WO 2004074417 · 2004 [cited by applicant]
WO 2006005551 · 2006 [cited by applicant]
WO 2008031104 · 2008 [cited by applicant]
WO 2008052031 · 2008 [cited by applicant]
WO 2011146182 · 2011 [cited by applicant]
WO 2013107822 · 2013 [cited by applicant]
Gaonkar et al., (In Vivo Efficacy of an Alcohol-based Surgical Hand Disinfectant Containing a Synergistic Combination of Ethylhexylglycerin and Preservatives). (Year 2006). [cited by applicant]
Search Report and International Application in International Application No. PCT/IB2019/059671 dated Jan. 14, 2020, 8 pages. [cited by applicant]
Dhavan et al., “Antibacterial and Antifungal Activities of 2,3,-pyrrolidinedione Derivatives Against Oral Pathogens”, Bioorganic and Medicinal Chemistry letters, vol. 26(5), Feb. 4, 2016, 11 pages. [cited by applicant]
Zeng et al., “Antifungal Activities of €-4-benzylidene-5 oxopyrrolidine-2carboxamides and 6-oxo-1,2,3,6-tetrahydropyridin-2-carboxamides Synthezed via Ugi Reaction From Baylis-hillman Bromides”, 2 [cited by applicant]
Hosseinzadeh et al., “An Overview on Chemistry and Biological Importance of Pyrrolidinone”, Current Organic Synthesis, vol. 14, 2017, 14 pages. [cited by applicant]
Cardinal Intellectual Property, Patent Search Report, Patentability Search, “Antimicrobial Compositions for Use in Sanitization, Disinfection and Sterilization of Various Surf”, Oct. 24, 2018, 13 pages. [cited by applicant]
Search Report in International Application No. PCT/CA2019/051740 dates Jan. 31, 2020. [cited by applicant]
De Schouwer et al., “Bio-based N-alkyl-2-pyrrolidones . . . decarboxylation of glutamic acid”, Green Chem., 2017, 19, 4919-4929. [cited by applicant]
Ansell et al., “The Acute Oral . . . of Selected N-Alkyl-2-Pyrrolidones”, Food and Chemical Toxicology, vol. 26, No. 5, pp. 475-479, 1988. [cited by applicant]
Phaechamud et al., “Characterization and Antimicrobial . . . Copolymer Thermosensitive Gel”, Indian Journal of Pharmaceutical Sciences, vol. 74, No. 6, Jan. 1, 2012. [cited by applicant]
Office Action dated Feb. 12, 2025, issued in Australian Patent Application No. 2024278581 (pp. 1-3). [cited by applicant]